Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis softbones October 28, 2020 0 Comments Print 🖨 PDF 📄To read more please click on the link below. Read Article
Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data Print 🖨 PDF 📄To read more please click on the link below. Read Article softbones October 28, 2020 0 Comments
Impact of muscular symptoms and/or pain on disease characteristics, disability, and quality of life in adult patients with hypophosphatasia: A cross-sectional analysis from the Global HPP Registry Print 🖨 PDF 📄To read more please click on the link below. Read Article Margaret Robb November 22, 2023 0 Comments
Circulating Micro-RNAs in Patients with Hypophosphatasia Results of the first micro-RNA analysis in HPP Print 🖨 PDF 📄To read more please click on the link below. Read Article Margaret Robb August 15, 2024 0 Comments
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia Print 🖨 PDF 📄To read more please click on the link below. Read Article Margaret Robb November 12, 2024 0 Comments
Radial HR‑pQCT and Finite Element Analysis in HPP Patients are Superior in Identifying Susceptibility to Fracture‑Associated Skeletal Afections Compared to DXA and Laboratory Tests Print 🖨 PDF 📄To read more please click on the link below.Read Article Denise Goodbar August 8, 2023 0 Comments
Responses